Evidence map›Paper›PMID 37383157›Full record

ArticleIranian journal of pathology2023

Frequency of HER2 Expression, MMR Deficiency, and PI3KCA Mutation in Pretreated Surgical Specimens of Patients with Esophageal Squamous Cell Carcinoma in Iran Cancer Institute.

Samaneh Salarvand Farzaneh Bagheri, Mahsa Gholizadeh, Sima Sharifi, Pooneh Panahi, Ebrahim Esmati, Marzieh Lashkari, Amirmohsen Jalaeefar, Mohammad Shirkhoda, Reza Shahsiah, Reza Ghalehtaki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samaneh Salarvand Farzaneh BagheriDepartment of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mahsa GholizadehRadiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sima SharifiDepartment of Clinical and Anatomical Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Pooneh PanahiDepartment of Clinical and Anatomical Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ebrahim EsmatiDepartment of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Marzieh LashkariDepartment of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amirmohsen JalaeefarDepartment of Oncosurgery, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad ShirkhodaDepartment of Oncosurgery, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Reza ShahsiahDepartment of Clinical and Anatomical Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Reza GhalehtakiDepartment of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Objective: Iran is located in the esophageal cancer geographical belt. As multiple genetic alterations are responsible for the molecular pathogenesis of esophageal squamous cell cancer (ESCC), the role and frequency of Methods: We carried out Results: None of the patients showed Conclusion:

Indexed as

DNA Mismatch RepairEsophageal NeoplasmsHER Family ReceptorKinaseSquamous Cell Carcinoma

Identifiers

PMID37383157
PMCPMC10293601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.